CIK: 0001440771 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 13, 2020
Total Value ($000): $51,630 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IVERIC BIO INC | 2,739,641 | $13,972 | 27.1% | $1.52 | — | COM | 46583P102 |
| LGND | LIGAND PHARMACEUTICALS | 92,407 | $10,336 | 20.0% | $56.68 | +11.9% | COM NEW | 53220K504 |
| — | CTI BIOPHARMA CORP | 4,068,191 | $4,719 | 9.1% | $2.16 | — | COM | 12648L601 |
| DMAC | DIAMEDICA THERAPEUTICS INC | 668,430 | $4,632 | 9.0% | $4.13 | +7.9% | COM NEW | 25253X207 |
| — | CATALYST BIOSCIENCES INC | 547,541 | $3,214 | 6.2% | $5.11 | — | COM NEW | 14888D208 |
| — | NEOS THERAPEUTICS INC | 4,447,026 | $3,046 | 5.9% | $1.80 | — | COM | 64052L106 |
| XOMA | XOMA CORP | 150,213 | $2,968 | 5.7% | $14.24 | +54.1% | COM NEW | 98419J206 |
| — | APOLLO ENDOSURGERY INC | 1,447,765 | $2,367 | 4.6% | $4.35 | — | COM | 03767D108 |
| CPIX | CUMBERLAND PHARMACEUTICALS | 676,592 | $2,253 | 4.4% | $5.80 | -37.3% | COM | 230770109 |
| — | ADAMAS PHARMACEUTICALS INC | 757,704 | $1,940 | 3.8% | $4.81 | — | COM | 00548A106 |
| — | CERECOR INC | 450,500 | $1,171 | 2.3% | $2.60 | — | COM | 15671L109 |
| — | PROGENITY INC | 96,135 | $865 | 1.7% | $9.00 | — | COM | 74319F107 |
| — | BRICKELL BIOTECH INC | 146,739 | $147 | 0.3% | $1.00 | — | COM | 10802T105 |